CME: Dry Eye Disease: Therapeutic Updates and Optimizing Treatment
Cost: FreeView Offer chevron_right
Dry eye disease (“dry eye”), also referred to as ocular surface disease and keratoconjunctivitis sicca, is a condition with a diverse group of etiologies and clinical presentations. Common symptoms include discomfort or pain, visual disturbance, and tear film instability. Compared with those without the condition, patients with dry eye experience higher rates of lost of work productivity, impaired of daily activities, medical visits, and sleep and mood disorders, and worse emotion well-being and overall quality of life. Although dry eye prevalence varies based on a variety of patient factors, estimates place the prevalence of dry eye as high as 19% of the adult population and more than 34% of the elderly population.
By the end of the session the participant will be able to:
- Describe the pathophysiology of dry eye with a focus on the factors affecting therapeutic mechanisms.
- Identify symptoms of dry eye and optimize diagnostic procedures to initiate treatment as early as possible.
- Accurately diagnose,** discuss, and apply treatment strategies in dry eye
- Evaluate available and emerging therapeutic options for dry eye, and individualize patient treatment regimens.
The following healthcare professionals: ophthalmology and optometry; physician assistants, nurse practitioners, nurses, and pharmacists who practice or are interested in ophthalmology; and any other healthcare professionals with an interest in or who clinically encounter patients with dry eye.